Rank | Gene Set | Z-score |
---|---|---|
1 | protein localization to cilium (GO:0061512) | 9.78181842 |
2 | regulation of cilium movement (GO:0003352) | 7.36467041 |
3 | protein polyglutamylation (GO:0018095) | 7.18387479 |
4 | regulation of chromatin binding (GO:0035561) | 7.16062393 |
5 | succinate metabolic process (GO:0006105) | 7.10617335 |
6 | tricarboxylic acid cycle (GO:0006099) | 6.55540594 |
7 | glomerular visceral epithelial cell development (GO:0072015) | 6.36476220 |
8 | peptidyl-arginine omega-N-methylation (GO:0035247) | 6.36338415 |
9 | regulation of female gonad development (GO:2000194) | 6.18998859 |
10 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 6.10656331 |
11 | glomerular epithelial cell development (GO:0072310) | 5.64815887 |
12 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 5.52623682 |
13 | peptidyl-arginine methylation (GO:0018216) | 5.28288047 |
14 | peptidyl-arginine N-methylation (GO:0035246) | 5.28288047 |
15 | behavioral response to cocaine (GO:0048148) | 5.28270037 |
16 | positive regulation of mitochondrial fission (GO:0090141) | 5.26876773 |
17 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 5.21403494 |
18 | axoneme assembly (GO:0035082) | 5.13626101 |
19 | auditory receptor cell differentiation (GO:0042491) | 4.97586614 |
20 | cilium morphogenesis (GO:0060271) | 4.92980328 |
21 | intraciliary transport (GO:0042073) | 4.91721920 |
22 | histone arginine methylation (GO:0034969) | 4.90273818 |
23 | microtubule severing (GO:0051013) | 4.82542831 |
24 | activation of protein kinase A activity (GO:0034199) | 4.65378227 |
25 | regulation of microtubule-based movement (GO:0060632) | 4.57627205 |
26 | detection of calcium ion (GO:0005513) | 4.54586910 |
27 | axonemal dynein complex assembly (GO:0070286) | 4.49528847 |
28 | dopamine receptor signaling pathway (GO:0007212) | 4.37396752 |
29 | protein maturation by protein folding (GO:0022417) | 4.32542647 |
30 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.27402114 |
31 | antibacterial humoral response (GO:0019731) | 4.26654138 |
32 | proteasome assembly (GO:0043248) | 4.26575949 |
33 | olfactory bulb development (GO:0021772) | 4.24821662 |
34 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.24541479 |
35 | negative regulation of cell aging (GO:0090344) | 4.18898989 |
36 | regulation of mitochondrial fission (GO:0090140) | 4.18496892 |
37 | regulation of cell aging (GO:0090342) | 4.16757605 |
38 | adipose tissue development (GO:0060612) | 4.14671064 |
39 | regulation of mitochondrial depolarization (GO:0051900) | 4.09821809 |
40 | positive regulation of B cell differentiation (GO:0045579) | 4.05419110 |
41 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.05039314 |
42 | cAMP biosynthetic process (GO:0006171) | 4.01255295 |
43 | innate immune response in mucosa (GO:0002227) | 3.97523846 |
44 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.96613252 |
45 | antimicrobial humoral response (GO:0019730) | 3.93467634 |
46 | cilium movement (GO:0003341) | 3.92732421 |
47 | establishment of integrated proviral latency (GO:0075713) | 3.75194195 |
48 | protein K6-linked ubiquitination (GO:0085020) | 3.73747610 |
49 | mitotic cell cycle arrest (GO:0071850) | 3.73335578 |
50 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.72976793 |
51 | cellular response to glucagon stimulus (GO:0071377) | 3.72860271 |
52 | oligosaccharide catabolic process (GO:0009313) | 3.72614245 |
53 | base-excision repair, AP site formation (GO:0006285) | 3.71272381 |
54 | regulation of synapse structural plasticity (GO:0051823) | 3.69811168 |
55 | response to caffeine (GO:0031000) | 3.68644178 |
56 | positive regulation of protein homooligomerization (GO:0032464) | 3.66937041 |
57 | chemical homeostasis within a tissue (GO:0048875) | 3.63999469 |
58 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.60585890 |
59 | establishment of viral latency (GO:0019043) | 3.60093271 |
60 | neuron cell-cell adhesion (GO:0007158) | 3.55352696 |
61 | mating behavior (GO:0007617) | 3.53341530 |
62 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.52564515 |
63 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.42424348 |
64 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.41503633 |
65 | regulation of spindle organization (GO:0090224) | 3.40254808 |
66 | negative regulation of ligase activity (GO:0051352) | 3.37343178 |
67 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.37343178 |
68 | peptidyl-arginine modification (GO:0018195) | 3.34184048 |
69 | cellular potassium ion transport (GO:0071804) | 3.34100438 |
70 | potassium ion transmembrane transport (GO:0071805) | 3.34100438 |
71 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.33482557 |
72 | glycogen catabolic process (GO:0005980) | 3.31911756 |
73 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.30640751 |
74 | melanosome transport (GO:0032402) | 3.29128531 |
75 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.28380581 |
76 | protein retention in ER lumen (GO:0006621) | 3.28237031 |
77 | mucosal immune response (GO:0002385) | 3.27840942 |
78 | magnesium ion transport (GO:0015693) | 3.21993180 |
79 | photoreceptor cell maintenance (GO:0045494) | 3.21770501 |
80 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.19619870 |
81 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.16859489 |
82 | nuclear envelope reassembly (GO:0031468) | 3.15722654 |
83 | mitotic nuclear envelope reassembly (GO:0007084) | 3.15722654 |
84 | female mating behavior (GO:0060180) | 3.14901040 |
85 | COPI coating of Golgi vesicle (GO:0048205) | 3.13824425 |
86 | Golgi transport vesicle coating (GO:0048200) | 3.13824425 |
87 | peptidyl-glutamic acid modification (GO:0018200) | 3.13008595 |
88 | ribosome assembly (GO:0042255) | 3.12755865 |
89 | regulation of protein kinase A signaling (GO:0010738) | 3.11880946 |
90 | atrial cardiac muscle cell action potential (GO:0086014) | 3.11831981 |
91 | organ or tissue specific immune response (GO:0002251) | 3.11729109 |
92 | membrane raft organization (GO:0031579) | 3.11559708 |
93 | establishment of melanosome localization (GO:0032401) | 3.11177429 |
94 | glucan catabolic process (GO:0009251) | 3.09892936 |
95 | pigment granule transport (GO:0051904) | 3.09259124 |
96 | regulation of sodium ion transmembrane transport (GO:1902305) | 3.07648883 |
97 | potassium ion homeostasis (GO:0055075) | 3.07603124 |
98 | morphogenesis of an endothelium (GO:0003159) | 3.07318783 |
99 | endothelial tube morphogenesis (GO:0061154) | 3.07318783 |
100 | barbed-end actin filament capping (GO:0051016) | 3.06398464 |
101 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.06063656 |
102 | relaxation of cardiac muscle (GO:0055119) | 3.05849642 |
103 | microtubule bundle formation (GO:0001578) | 3.05653664 |
104 | brain morphogenesis (GO:0048854) | 3.05589781 |
105 | response to amphetamine (GO:0001975) | 3.05268391 |
106 | male sex determination (GO:0030238) | 3.04306168 |
107 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.04044716 |
108 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.03653016 |
109 | potassium ion transport (GO:0006813) | 3.02214316 |
110 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.02129416 |
111 | sensory perception of smell (GO:0007608) | 23.8865984 |
112 | melanosome localization (GO:0032400) | 2.98024544 |
113 | regulation of cell communication by electrical coupling (GO:0010649) | 2.96894115 |
114 | negative regulation of astrocyte differentiation (GO:0048712) | 2.96768298 |
115 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.96701794 |
116 | positive regulation of protein oligomerization (GO:0032461) | 2.96616780 |
117 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.96216596 |
118 | secondary heart field specification (GO:0003139) | 2.95594426 |
119 | heart field specification (GO:0003128) | 2.95594426 |
120 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.94016079 |
121 | response to glucagon (GO:0033762) | 2.93866690 |
122 | deoxyribonucleotide catabolic process (GO:0009264) | 2.93856713 |
123 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.93715307 |
124 | establishment of pigment granule localization (GO:0051905) | 2.93027136 |
125 | membrane repolarization during action potential (GO:0086011) | 2.92985808 |
126 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.91606080 |
127 | hair cell differentiation (GO:0035315) | 2.90626251 |
128 | ovulation cycle (GO:0042698) | 2.89740534 |
129 | DNA excision (GO:0044349) | 2.89710905 |
130 | nucleotide-excision repair, DNA damage removal (GO:0000718) | 2.89710905 |
131 | epithelial cilium movement (GO:0003351) | 2.89702664 |
132 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.89529638 |
133 | cardiac conduction (GO:0061337) | 2.88439811 |
134 | deoxyribose phosphate catabolic process (GO:0046386) | 2.87810921 |
135 | axonal fasciculation (GO:0007413) | 2.86787217 |
136 | striatum development (GO:0021756) | 2.85234020 |
137 | galactose catabolic process (GO:0019388) | 2.84838322 |
138 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.83847988 |
139 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.83847988 |
140 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.83548425 |
141 | negative regulation of sodium ion transport (GO:0010766) | 2.82695019 |
142 | response to inactivity (GO:0014854) | 2.82127052 |
143 | pigment granule localization (GO:0051875) | 2.81934812 |
144 | negative regulation of protein ubiquitination (GO:0031397) | 2.81789609 |
145 | regulation of female receptivity (GO:0045924) | 2.81736575 |
146 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.81597036 |
147 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.80965570 |
148 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.80965570 |
149 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.80965570 |
150 | regulation of protein homooligomerization (GO:0032462) | 2.80686641 |
151 | regulation of sodium ion transport (GO:0002028) | 2.79164641 |
152 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.78472975 |
153 | inner ear receptor cell differentiation (GO:0060113) | 2.77755675 |
154 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.77512853 |
155 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.77512853 |
156 | lipopolysaccharide metabolic process (GO:0008653) | 2.75585927 |
157 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.74052809 |
158 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.74052809 |
159 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.72678460 |
160 | cellular polysaccharide catabolic process (GO:0044247) | 2.71768123 |
161 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.71533642 |
162 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.71262635 |
163 | muscle cell migration (GO:0014812) | 2.70881145 |
164 | potassium ion export (GO:0071435) | 2.70496781 |
165 | cellular copper ion homeostasis (GO:0006878) | 2.70006839 |
166 | response to gravity (GO:0009629) | 2.69531041 |
167 | nerve growth factor signaling pathway (GO:0038180) | 2.68697193 |
168 | cilium assembly (GO:0042384) | 2.68323483 |
169 | neuron apoptotic process (GO:0051402) | 2.68097079 |
170 | base-excision repair (GO:0006284) | 2.67438237 |
171 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.66048482 |
172 | protein K11-linked ubiquitination (GO:0070979) | 2.65870927 |
173 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.65450098 |
174 | connective tissue development (GO:0061448) | 2.65277006 |
175 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.64685490 |
176 | telomere maintenance via recombination (GO:0000722) | 2.64117608 |
177 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.62938387 |
178 | facial nerve structural organization (GO:0021612) | 2.62571492 |
179 | response to arsenic-containing substance (GO:0046685) | 2.62255350 |
180 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.62207959 |
181 | negative regulation of protein kinase B signaling (GO:0051898) | 2.61985806 |
182 | forebrain neuron development (GO:0021884) | 2.61572584 |
183 | reproductive behavior (GO:0019098) | 2.60624593 |
184 | cAMP metabolic process (GO:0046058) | 2.60541158 |
185 | regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108) | 2.58965598 |
186 | sensory perception of taste (GO:0050909) | 2.58500685 |
187 | negative regulation of cation channel activity (GO:2001258) | 2.58297388 |
188 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.57384992 |
189 | positive regulation of actin filament depolymerization (GO:0030836) | 2.57314235 |
190 | GDP-mannose metabolic process (GO:0019673) | 2.55722970 |
191 | positive regulation of lamellipodium organization (GO:1902745) | 2.55629181 |
192 | skin morphogenesis (GO:0043589) | 2.54699755 |
193 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.54231697 |
194 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.53717037 |
195 | adenosine receptor signaling pathway (GO:0001973) | 2.50179885 |
196 | low-density lipoprotein particle clearance (GO:0034383) | 2.49449910 |
197 | response to nerve growth factor (GO:1990089) | 2.48244302 |
198 | sensory perception of chemical stimulus (GO:0007606) | 13.7764837 |
199 | protein insertion into membrane (GO:0051205) | 12.4768260 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.78551105 |
2 | TAF15_26573619_Chip-Seq_HEK293_Human | 4.09954697 |
3 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.91132398 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.26184087 |
5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.07467599 |
6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.92431773 |
7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.91637714 |
8 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.87171823 |
9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.83995753 |
10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.77086989 |
11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.52866751 |
12 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 2.47504851 |
13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.45696334 |
14 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.38847758 |
15 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.37289431 |
16 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.34843064 |
17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.34287183 |
18 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.17143247 |
19 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.15560040 |
20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.09627666 |
21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.06270133 |
22 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.02686780 |
23 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00980939 |
24 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.97231630 |
25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.96075810 |
26 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.93768032 |
27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.91807350 |
28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.87119278 |
29 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.87119278 |
30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.86151525 |
31 | ATF3_27146783_Chip-Seq_COLON_Human | 1.84655037 |
32 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.81418929 |
33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.80838773 |
34 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.79517898 |
35 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.78332511 |
36 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.77527795 |
37 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.74774621 |
38 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.72746707 |
39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71872194 |
40 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.71033910 |
41 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.70108716 |
42 | KDM2B_26808549_Chip-Seq_K562_Human | 1.68394363 |
43 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.67821214 |
44 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66982771 |
45 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.66152954 |
46 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.64919385 |
47 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.64648424 |
48 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.64438553 |
49 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.62589249 |
50 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.61772156 |
51 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.60116297 |
52 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.59893820 |
53 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.58989220 |
54 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.58362200 |
55 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.58312797 |
56 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.57920916 |
57 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.57869102 |
58 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.56566132 |
59 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.56034757 |
60 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.54026063 |
61 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.52758741 |
62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51628968 |
63 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.51515882 |
64 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48724232 |
65 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.48284379 |
66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.47724273 |
67 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.47654450 |
68 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.47479124 |
69 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.47097527 |
70 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.45268040 |
71 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.43416023 |
72 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.42496037 |
73 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.42325401 |
74 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.41906241 |
75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41754947 |
76 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.41346506 |
77 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.41112086 |
78 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.40092301 |
79 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.40025149 |
80 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.38449395 |
81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.37865616 |
82 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.37710200 |
83 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.37030121 |
84 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36529098 |
85 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.35829661 |
86 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.35825581 |
87 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.34850615 |
88 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.34793720 |
89 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.34259608 |
90 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.32125812 |
91 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31544756 |
92 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.30441183 |
93 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.30096305 |
94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28209608 |
95 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.28193756 |
96 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.28145538 |
97 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.27181965 |
98 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25815959 |
99 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25335717 |
100 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.25278029 |
101 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.25065104 |
102 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.24530884 |
103 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23332686 |
104 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22775400 |
105 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.22575861 |
106 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.22575861 |
107 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21900262 |
108 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.21632224 |
109 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.21473534 |
110 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.21202305 |
111 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20646100 |
112 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20487423 |
113 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.19750140 |
114 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.19496200 |
115 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.19393110 |
116 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19157226 |
117 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18951860 |
118 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.18578877 |
119 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18578877 |
120 | VDR_22108803_ChIP-Seq_LS180_Human | 1.18069246 |
121 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16771126 |
122 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16103416 |
123 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14746252 |
124 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14424626 |
125 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.14283673 |
126 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14246777 |
127 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12534540 |
128 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.12338606 |
129 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11898942 |
130 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.11755653 |
131 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.11203426 |
132 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10792832 |
133 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09952663 |
134 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09794638 |
135 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09730566 |
136 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09423418 |
137 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.08970966 |
138 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08590740 |
139 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.07983368 |
140 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07440635 |
141 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.06955386 |
142 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06594257 |
143 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.06185773 |
144 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06184000 |
145 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05962297 |
146 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05849164 |
147 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.05371930 |
148 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05311953 |
149 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.04290956 |
150 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.04225875 |
151 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.04203591 |
152 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.04081407 |
153 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.03569425 |
154 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.02239233 |
155 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02186649 |
156 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01510484 |
157 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01268035 |
158 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00917528 |
159 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00711034 |
160 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00073867 |
161 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.99346942 |
162 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.99334838 |
163 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98120214 |
164 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97935620 |
165 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.97552016 |
166 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.97400987 |
167 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.97310794 |
168 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.96741264 |
169 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.96582372 |
170 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.96235606 |
171 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.96054698 |
172 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95712898 |
173 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.95590158 |
174 | P68_20966046_ChIP-Seq_HELA_Human | 0.95217334 |
175 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.94496694 |
176 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94417377 |
177 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.94237823 |
178 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.93803665 |
179 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93042045 |
180 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.92841376 |
181 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92671723 |
182 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.92516412 |
183 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.91734526 |
184 | NCOR_22424771_ChIP-Seq_293T_Human | 0.91353175 |
185 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.91338973 |
186 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.90831307 |
187 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.90473713 |
188 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90340999 |
189 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90100200 |
190 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.87829659 |
191 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.87811270 |
192 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.87258771 |
193 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.87019466 |
194 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.84620970 |
195 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.84528246 |
196 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.83829750 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008789_abnormal_olfactory_epithelium | 4.78919353 |
2 | MP0000566_synostosis | 4.49595959 |
3 | MP0005499_abnormal_olfactory_system | 4.40725955 |
4 | MP0005394_taste/olfaction_phenotype | 4.40725955 |
5 | MP0003191_abnormal_cellular_cholesterol | 3.73100470 |
6 | MP0005257_abnormal_intraocular_pressure | 2.99217878 |
7 | MP0005645_abnormal_hypothalamus_physiol | 2.92202630 |
8 | MP0000751_myopathy | 2.77414726 |
9 | MP0009840_abnormal_foam_cell | 2.71506103 |
10 | MP0001986_abnormal_taste_sensitivity | 2.65551648 |
11 | MP0003806_abnormal_nucleotide_metabolis | 2.54711593 |
12 | MP0002184_abnormal_innervation | 2.49274028 |
13 | MP0003878_abnormal_ear_physiology | 2.28572105 |
14 | MP0005377_hearing/vestibular/ear_phenot | 2.28572105 |
15 | MP0000749_muscle_degeneration | 2.18511728 |
16 | MP0002822_catalepsy | 2.13010192 |
17 | MP0000343_altered_response_to | 2.10909832 |
18 | MP0008260_abnormal_autophagy | 2.07391244 |
19 | MP0003656_abnormal_erythrocyte_physiolo | 2.04830438 |
20 | MP0003950_abnormal_plasma_membrane | 2.00603782 |
21 | MP0001984_abnormal_olfaction | 15.4859957 |
22 | MP0009278_abnormal_bone_marrow | 1.97039346 |
23 | MP0000747_muscle_weakness | 1.93506141 |
24 | MP0009780_abnormal_chondrocyte_physiolo | 1.85608388 |
25 | MP0001485_abnormal_pinna_reflex | 1.85324597 |
26 | MP0005083_abnormal_biliary_tract | 1.81933665 |
27 | MP0000490_abnormal_crypts_of | 1.75533004 |
28 | MP0000858_altered_metastatic_potential | 1.72274154 |
29 | MP0000750_abnormal_muscle_regeneration | 1.71140717 |
30 | MP0003566_abnormal_cell_adhesion | 1.69364854 |
31 | MP0002332_abnormal_exercise_endurance | 1.67999550 |
32 | MP0005084_abnormal_gallbladder_morpholo | 1.67595640 |
33 | MP0002160_abnormal_reproductive_system | 1.65967436 |
34 | MP0003705_abnormal_hypodermis_morpholog | 1.63525173 |
35 | MP0003880_abnormal_central_pattern | 1.63379493 |
36 | MP0002653_abnormal_ependyma_morphology | 1.62270401 |
37 | MP0001853_heart_inflammation | 1.62255167 |
38 | MP0003329_amyloid_beta_deposits | 1.60971539 |
39 | MP0003315_abnormal_perineum_morphology | 1.58927052 |
40 | MP0000372_irregular_coat_pigmentation | 1.58565535 |
41 | MP0002928_abnormal_bile_duct | 1.58377773 |
42 | MP0009697_abnormal_copulation | 1.57816028 |
43 | MP0003221_abnormal_cardiomyocyte_apopto | 1.45562029 |
44 | MP0002734_abnormal_mechanical_nocicepti | 1.43065400 |
45 | MP0001542_abnormal_bone_strength | 1.41726260 |
46 | MP0009053_abnormal_anal_canal | 1.35778476 |
47 | MP0001299_abnormal_eye_distance/ | 1.34962165 |
48 | MP0003453_abnormal_keratinocyte_physiol | 1.34665263 |
49 | MP0003077_abnormal_cell_cycle | 1.33122684 |
50 | MP0004957_abnormal_blastocyst_morpholog | 1.33084297 |
51 | MP0002557_abnormal_social/conspecific_i | 1.31698174 |
52 | MP0002752_abnormal_somatic_nervous | 1.30620490 |
53 | MP0001727_abnormal_embryo_implantation | 1.29682374 |
54 | MP0002877_abnormal_melanocyte_morpholog | 1.28783395 |
55 | MP0001486_abnormal_startle_reflex | 1.26252297 |
56 | MP0002060_abnormal_skin_morphology | 1.24169660 |
57 | MP0005085_abnormal_gallbladder_physiolo | 1.20256080 |
58 | MP0003252_abnormal_bile_duct | 1.19702933 |
59 | MP0005501_abnormal_skin_physiology | 1.18835989 |
60 | MP0002233_abnormal_nose_morphology | 1.18211160 |
61 | MP0000516_abnormal_urinary_system | 1.17985807 |
62 | MP0005367_renal/urinary_system_phenotyp | 1.17985807 |
63 | MP0009764_decreased_sensitivity_to | 1.15797536 |
64 | MP0003436_decreased_susceptibility_to | 1.15268583 |
65 | MP0005330_cardiomyopathy | 1.13626961 |
66 | MP0002272_abnormal_nervous_system | 1.13401746 |
67 | MP0005410_abnormal_fertilization | 1.11988572 |
68 | MP0001188_hyperpigmentation | 1.10720326 |
69 | MP0004272_abnormal_basement_membrane | 1.10526998 |
70 | MP0002148_abnormal_hypersensitivity_rea | 1.09426023 |
71 | MP0000358_abnormal_cell_content/ | 1.06344464 |
72 | MP0003186_abnormal_redox_activity | 1.05439745 |
73 | MP0002909_abnormal_adrenal_gland | 1.03786277 |
74 | MP0005646_abnormal_pituitary_gland | 1.02808545 |
75 | MP0008875_abnormal_xenobiotic_pharmacok | 1.02790359 |
76 | MP0000681_abnormal_thyroid_gland | 1.00582334 |
77 | MP0005451_abnormal_body_composition | 1.00489281 |
78 | MP0003635_abnormal_synaptic_transmissio | 0.99619856 |
79 | MP0003123_paternal_imprinting | 0.98972802 |
80 | MP0002882_abnormal_neuron_morphology | 0.98643835 |
81 | MP0000537_abnormal_urethra_morphology | 0.96686528 |
82 | MP0002796_impaired_skin_barrier | 0.94624524 |
83 | MP0001216_abnormal_epidermal_layer | 0.93555570 |
84 | MP0004270_analgesia | 0.93330078 |
85 | MP0005623_abnormal_meninges_morphology | 0.93308095 |
86 | MP0000778_abnormal_nervous_system | 0.92323967 |
87 | MP0000313_abnormal_cell_death | 0.91677423 |
88 | MP0005621_abnormal_cell_physiology | 0.91283851 |
89 | MP0005166_decreased_susceptibility_to | 0.88758269 |
90 | MP0005384_cellular_phenotype | 0.86021757 |
91 | MP0000604_amyloidosis | 0.85964288 |
92 | MP0005164_abnormal_response_to | 0.85910421 |
93 | MP0001545_abnormal_hematopoietic_system | 0.83664440 |
94 | MP0005397_hematopoietic_system_phenotyp | 0.83664440 |
95 | MP0008438_abnormal_cutaneous_collagen | 0.83585290 |
96 | MP0002063_abnormal_learning/memory/cond | 0.83514923 |
97 | MP0003111_abnormal_nucleus_morphology | 0.83079292 |
98 | MP0006054_spinal_hemorrhage | 0.81634546 |
99 | MP0005197_abnormal_uvea_morphology | 0.81578115 |
100 | MP0001533_abnormal_skeleton_physiology | 0.80221935 |
101 | MP0009931_abnormal_skin_appearance | 0.77975407 |
102 | MP0003091_abnormal_cell_migration | 0.76912971 |
103 | MP0000003_abnormal_adipose_tissue | 0.76450763 |
104 | MP0002111_abnormal_tail_morphology | 0.75697194 |
105 | MP0005389_reproductive_system_phenotype | 0.75193125 |
106 | MP0002019_abnormal_tumor_incidence | 0.75142747 |
107 | MP0003075_altered_response_to | 0.74956772 |
108 | MP0005390_skeleton_phenotype | 0.74664668 |
109 | MP0002152_abnormal_brain_morphology | 0.73907429 |
110 | MP0004811_abnormal_neuron_physiology | 0.72892167 |
111 | MP0002254_reproductive_system_inflammat | 0.72735139 |
112 | MP0005187_abnormal_penis_morphology | 0.72386011 |
113 | MP0005551_abnormal_eye_electrophysiolog | 0.71597159 |
114 | MP0005464_abnormal_platelet_physiology | 0.71399847 |
115 | MP0009333_abnormal_splenocyte_physiolog | 0.70768447 |
116 | MP0006082_CNS_inflammation | 0.70327459 |
117 | MP0004947_skin_inflammation | 0.67916331 |
118 | MP0003279_aneurysm | 0.66873247 |
119 | MP0001970_abnormal_pain_threshold | 0.66620480 |
120 | MP0010771_integument_phenotype | 0.66169423 |
121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.65790309 |
122 | MP0005360_urolithiasis | 0.65662979 |
123 | MP0001243_abnormal_dermal_layer | 0.65100128 |
124 | MP0008469_abnormal_protein_level | 0.64374163 |
125 | MP0002572_abnormal_emotion/affect_behav | 0.64327402 |
126 | MP0002210_abnormal_sex_determination | 0.62513348 |
127 | MP0004859_abnormal_synaptic_plasticity | 0.61091445 |
128 | MP0003942_abnormal_urinary_system | 0.60834166 |
129 | MP0005409_darkened_coat_color | 0.60483181 |
130 | MP0001529_abnormal_vocalization | 0.60388310 |
131 | MP0004264_abnormal_extraembryonic_tissu | 0.59550570 |
132 | MP0008057_abnormal_DNA_replication | 0.59035457 |
133 | MP0010094_abnormal_chromosome_stability | 0.58608613 |
134 | MP0002452_abnormal_antigen_presenting | 0.58426648 |
135 | MP0002229_neurodegeneration | 0.58221967 |
136 | MP0002064_seizures | 0.57274763 |
137 | MP0009046_muscle_twitch | 0.56454076 |
138 | MP0004742_abnormal_vestibular_system | 0.56352534 |
139 | MP0008874_decreased_physiological_sensi | 0.55853480 |
140 | MP0005174_abnormal_tail_pigmentation | 0.55543027 |
141 | MP0001293_anophthalmia | 0.54363043 |
142 | MP0004147_increased_porphyrin_level | 0.54064953 |
143 | MP0003634_abnormal_glial_cell | 0.53402374 |
144 | MP0003693_abnormal_embryo_hatching | 0.52962103 |
145 | MP0001270_distended_abdomen | 0.51431572 |
146 | MP0006276_abnormal_autonomic_nervous | 0.50942704 |
147 | MP0009745_abnormal_behavioral_response | 0.50186510 |
148 | MP0005423_abnormal_somatic_nervous | 0.49421325 |
149 | MP0004133_heterotaxia | 0.48797687 |
150 | MP0003633_abnormal_nervous_system | 0.48173908 |
151 | MP0004484_altered_response_of | 0.47901413 |
152 | MP0002295_abnormal_pulmonary_circulatio | 0.47796622 |
153 | MP0001963_abnormal_hearing_physiology | 0.47760605 |
154 | MP0002067_abnormal_sensory_capabilities | 0.47578065 |
155 | MP0000538_abnormal_urinary_bladder | 0.45766077 |
156 | MP0002938_white_spotting | 0.45690691 |
157 | MP0010234_abnormal_vibrissa_follicle | 0.45118966 |
158 | MP0003879_abnormal_hair_cell | 0.44202288 |
159 | MP0010030_abnormal_orbit_morphology | 0.44127634 |
160 | MP0000026_abnormal_inner_ear | 0.43961246 |
161 | MP0004145_abnormal_muscle_electrophysio | 0.43152125 |
162 | MP0004510_myositis | 0.41678275 |
163 | MP0003861_abnormal_nervous_system | 0.40979103 |
164 | MP0005195_abnormal_posterior_eye | 0.40886339 |
165 | MP0000534_abnormal_ureter_morphology | 0.39473270 |
166 | MP0005165_increased_susceptibility_to | 0.36679652 |
167 | MP0001501_abnormal_sleep_pattern | 0.35802233 |
168 | MP0002751_abnormal_autonomic_nervous | 0.34289977 |
169 | MP0000049_abnormal_middle_ear | 0.34080693 |
170 | MP0006035_abnormal_mitochondrial_morpho | 0.32451509 |
171 | MP0005058_abnormal_lysosome_morphology | 0.32010417 |
172 | MP0002066_abnormal_motor_capabilities/c | 0.31905267 |
173 | MP0003943_abnormal_hepatobiliary_system | 0.31407753 |
174 | MP0000955_abnormal_spinal_cord | 0.30419699 |
175 | MP0003646_muscle_fatigue | 0.29330671 |
176 | MP0005365_abnormal_bile_salt | 0.29279835 |
177 | MP0006036_abnormal_mitochondrial_physio | 0.29162356 |
178 | MP0000631_abnormal_neuroendocrine_gland | 0.29112820 |
179 | MP0004782_abnormal_surfactant_physiolog | 0.29041287 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperventilation (HP:0002883) | 8.74532745 |
2 | Retinal dysplasia (HP:0007973) | 7.36519031 |
3 | Methylmalonic aciduria (HP:0012120) | 6.95798429 |
4 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 6.45405883 |
5 | Abnormal ciliary motility (HP:0012262) | 6.42951569 |
6 | Abnormality of macular pigmentation (HP:0008002) | 6.34208352 |
7 | Abnormal respiratory motile cilium physiology (HP:0012261) | 6.21075099 |
8 | Abnormal respiratory motile cilium morphology (HP:0005938) | 6.18840747 |
9 | Abnormal respiratory epithelium morphology (HP:0012253) | 6.18840747 |
10 | Limb dystonia (HP:0002451) | 5.88862418 |
11 | Bifid tongue (HP:0010297) | 5.76570561 |
12 | Molar tooth sign on MRI (HP:0002419) | 5.46875586 |
13 | Abnormality of midbrain morphology (HP:0002418) | 5.46875586 |
14 | Rhinitis (HP:0012384) | 5.19008116 |
15 | Palpitations (HP:0001962) | 5.10437862 |
16 | Dysphonia (HP:0001618) | 4.56207215 |
17 | Upper limb muscle weakness (HP:0003484) | 4.51293917 |
18 | Atonic seizures (HP:0010819) | 4.15148576 |
19 | Abolished electroretinogram (ERG) (HP:0000550) | 4.02930717 |
20 | Torticollis (HP:0000473) | 3.95932630 |
21 | Anosmia (HP:0000458) | 3.93678840 |
22 | Gait imbalance (HP:0002141) | 3.81817457 |
23 | Congenital primary aphakia (HP:0007707) | 3.74878099 |
24 | Unsteady gait (HP:0002317) | 3.69971478 |
25 | Hand muscle atrophy (HP:0009130) | 3.67187558 |
26 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.61934471 |
27 | Nephrogenic diabetes insipidus (HP:0009806) | 3.60957489 |
28 | Medial flaring of the eyebrow (HP:0010747) | 3.55058820 |
29 | Syncope (HP:0001279) | 3.53167351 |
30 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.52225848 |
31 | Distal upper limb amyotrophy (HP:0007149) | 3.39202599 |
32 | Upper limb amyotrophy (HP:0009129) | 3.39202599 |
33 | Absent/shortened dynein arms (HP:0200106) | 3.35430308 |
34 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.35430308 |
35 | Craniofacial dystonia (HP:0012179) | 3.32826523 |
36 | Bronchiectasis (HP:0002110) | 3.25846016 |
37 | Postaxial hand polydactyly (HP:0001162) | 3.24434571 |
38 | Hyperglycinemia (HP:0002154) | 3.23051550 |
39 | Synostosis involving the elbow (HP:0003938) | 3.21418960 |
40 | Humeroradial synostosis (HP:0003041) | 3.21418960 |
41 | Hypothermia (HP:0002045) | 3.20398487 |
42 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.15585067 |
43 | Chronic sinusitis (HP:0011109) | 3.14434237 |
44 | Prolonged neonatal jaundice (HP:0006579) | 3.10686552 |
45 | Occipital encephalocele (HP:0002085) | 3.10132462 |
46 | Poor coordination (HP:0002370) | 3.08306906 |
47 | Increased serum pyruvate (HP:0003542) | 3.07334809 |
48 | Adrenal hypoplasia (HP:0000835) | 3.06339266 |
49 | Premature rupture of membranes (HP:0001788) | 3.06208462 |
50 | Chronic hepatic failure (HP:0100626) | 3.05528397 |
51 | Focal dystonia (HP:0004373) | 3.04858852 |
52 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.04736223 |
53 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.04736223 |
54 | Abnormality of glycolipid metabolism (HP:0010969) | 3.04736223 |
55 | Abnormality of glycolysis (HP:0004366) | 3.04391748 |
56 | Osteolytic defects of the hand bones (HP:0009699) | 3.04359875 |
57 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.04359875 |
58 | Dicarboxylic aciduria (HP:0003215) | 3.04297185 |
59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.04297185 |
60 | Pancreatic fibrosis (HP:0100732) | 2.97531692 |
61 | Glucose intolerance (HP:0000833) | 2.96613548 |
62 | Severe visual impairment (HP:0001141) | 2.96064403 |
63 | True hermaphroditism (HP:0010459) | 2.96030110 |
64 | Chronic bronchitis (HP:0004469) | 2.92596855 |
65 | Vaginal atresia (HP:0000148) | 2.91421733 |
66 | Renal hypoplasia (HP:0000089) | 2.87325288 |
67 | Febrile seizures (HP:0002373) | 2.79742109 |
68 | Genital tract atresia (HP:0001827) | 2.76650676 |
69 | Abnormality of dentin (HP:0010299) | 2.75281218 |
70 | Pili torti (HP:0003777) | 2.74901555 |
71 | Abnormality of placental membranes (HP:0011409) | 2.68122225 |
72 | Amniotic constriction ring (HP:0009775) | 2.68122225 |
73 | Hypophosphatemia (HP:0002148) | 2.67764044 |
74 | Decreased central vision (HP:0007663) | 2.67644215 |
75 | Supernumerary spleens (HP:0009799) | 2.67380220 |
76 | Poikilocytosis (HP:0004447) | 2.66126243 |
77 | Absence seizures (HP:0002121) | 2.60791625 |
78 | Myokymia (HP:0002411) | 2.55135922 |
79 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.54563142 |
80 | Vertebral compression fractures (HP:0002953) | 2.54025414 |
81 | Pheochromocytoma (HP:0002666) | 2.52642898 |
82 | Prolonged QT interval (HP:0001657) | 2.49657967 |
83 | Hypoalphalipoproteinemia (HP:0003233) | 2.48970398 |
84 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.48941117 |
85 | Distal lower limb muscle weakness (HP:0009053) | 2.48788937 |
86 | Conjunctival hamartoma (HP:0100780) | 2.47731818 |
87 | Rough bone trabeculation (HP:0100670) | 2.47218969 |
88 | Abnormality of sodium homeostasis (HP:0010931) | 2.46948947 |
89 | Multiple lipomas (HP:0001012) | 2.45872425 |
90 | Insulin resistance (HP:0000855) | 2.41422061 |
91 | Neuroendocrine neoplasm (HP:0100634) | 2.41326596 |
92 | Entropion (HP:0000621) | 2.39522650 |
93 | Hyperacusis (HP:0010780) | 2.37130723 |
94 | Complete atrioventricular canal defect (HP:0001674) | 2.36494044 |
95 | Median cleft lip (HP:0000161) | 2.36302390 |
96 | Short nail (HP:0001799) | 2.35238326 |
97 | Nasal polyposis (HP:0100582) | 2.34166527 |
98 | Bone cyst (HP:0012062) | 2.30864075 |
99 | Diaphragmatic weakness (HP:0009113) | 2.29728493 |
100 | Type I transferrin isoform profile (HP:0003642) | 2.27304280 |
101 | Respiratory failure (HP:0002878) | 2.26226189 |
102 | Oculomotor apraxia (HP:0000657) | 2.25283794 |
103 | Distal lower limb amyotrophy (HP:0008944) | 2.25262319 |
104 | Hypertriglyceridemia (HP:0002155) | 2.24642786 |
105 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.24136431 |
106 | Increased connective tissue (HP:0009025) | 2.21116294 |
107 | Hepatosplenomegaly (HP:0001433) | 2.20626551 |
108 | Tetraparesis (HP:0002273) | 2.20351725 |
109 | Recurrent sinusitis (HP:0011108) | 2.18170203 |
110 | Cystic liver disease (HP:0006706) | 2.17358485 |
111 | Abnormal biliary tract physiology (HP:0012439) | 2.15904529 |
112 | Bile duct proliferation (HP:0001408) | 2.15904529 |
113 | Vacuolated lymphocytes (HP:0001922) | 2.15509797 |
114 | Microglossia (HP:0000171) | 2.11499561 |
115 | Delayed CNS myelination (HP:0002188) | 2.08888890 |
116 | Sudden death (HP:0001699) | 2.07897145 |
117 | Lactic acidosis (HP:0003128) | 2.07435183 |
118 | Abnormal trabecular bone morphology (HP:0100671) | 2.07211571 |
119 | Abnormal hair laboratory examination (HP:0003328) | 2.06719409 |
120 | Pancreatic cysts (HP:0001737) | 2.06102013 |
121 | Retinitis pigmentosa (HP:0000510) | 2.03397989 |
122 | Central scotoma (HP:0000603) | 2.02806135 |
123 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.02159963 |
124 | Xerostomia (HP:0000217) | 2.01956301 |
125 | Nephronophthisis (HP:0000090) | 2.00557129 |
126 | Overriding aorta (HP:0002623) | 2.00500505 |
127 | Congenital hepatic fibrosis (HP:0002612) | 1.99382093 |
128 | Abnormality of the vocal cords (HP:0008777) | 1.97372318 |
129 | Atrioventricular canal defect (HP:0006695) | 1.96758619 |
130 | Constricted visual fields (HP:0001133) | 1.96345857 |
131 | Confusion (HP:0001289) | 1.95900888 |
132 | Dysostosis multiplex (HP:0000943) | 1.95821482 |
133 | Abnormality of permanent molar morphology (HP:0011071) | 1.95491830 |
134 | Abnormality of the dental root (HP:0006486) | 1.95491830 |
135 | Taurodontia (HP:0000679) | 1.95491830 |
136 | Acanthosis nigricans (HP:0000956) | 1.93404902 |
137 | Axonal loss (HP:0003447) | 1.92887807 |
138 | Sparse eyelashes (HP:0000653) | 1.92792050 |
139 | Growth hormone excess (HP:0000845) | 1.92575965 |
140 | Decreased subcutaneous fat (HP:0001002) | 1.91517102 |
141 | Abnormal glucose tolerance (HP:0001952) | 1.91180833 |
142 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.88810845 |
143 | Dialeptic seizures (HP:0011146) | 1.87870271 |
144 | Vascular calcification (HP:0004934) | 1.87553568 |
145 | Hypertensive crisis (HP:0100735) | 1.87512208 |
146 | Trismus (HP:0000211) | 1.86920256 |
147 | Interstitial pulmonary disease (HP:0006530) | 1.86540326 |
148 | Loss of speech (HP:0002371) | 1.83425924 |
149 | Abnormality of the nasal mucosa (HP:0000433) | 1.83344753 |
150 | Abnormality of alanine metabolism (HP:0010916) | 1.83169617 |
151 | Hyperalaninemia (HP:0003348) | 1.83169617 |
152 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.83169617 |
153 | Nonimmune hydrops fetalis (HP:0001790) | 1.83166509 |
154 | Abnormality of molar morphology (HP:0011070) | 1.82608445 |
155 | Abnormality of molar (HP:0011077) | 1.82608445 |
156 | Insomnia (HP:0100785) | 1.81878897 |
157 | Abnormal protein glycosylation (HP:0012346) | 1.81627389 |
158 | Abnormal glycosylation (HP:0012345) | 1.81627389 |
159 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.81627389 |
160 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.81627389 |
161 | Attenuation of retinal blood vessels (HP:0007843) | 1.80228490 |
162 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.79184094 |
163 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.79091310 |
164 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.79091310 |
165 | Flat cornea (HP:0007720) | 1.78366723 |
166 | Upper motor neuron abnormality (HP:0002127) | 1.78325051 |
167 | Hyperglycinuria (HP:0003108) | 1.76964391 |
168 | Hyperhidrosis (HP:0000975) | 1.76381484 |
169 | Cerebral hemorrhage (HP:0001342) | 1.76332176 |
170 | Toxemia of pregnancy (HP:0100603) | 1.76170088 |
171 | Tubulointerstitial nephritis (HP:0001970) | 1.75609874 |
172 | Elfin facies (HP:0004428) | 1.75496637 |
173 | Aganglionic megacolon (HP:0002251) | 1.75292741 |
174 | Recurrent otitis media (HP:0000403) | 1.75209312 |
175 | Facial cleft (HP:0002006) | 1.75068889 |
176 | Myocardial infarction (HP:0001658) | 1.74602163 |
177 | Left ventricular hypertrophy (HP:0001712) | 1.74310096 |
178 | Primary atrial arrhythmia (HP:0001692) | 1.73352438 |
179 | Absent eyebrow (HP:0002223) | 1.73152561 |
180 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.72393761 |
181 | Aplasia of the phalanges of the hand (HP:0009802) | 1.72393761 |
182 | Aplasia involving bones of the extremities (HP:0009825) | 1.72393761 |
183 | Decreased testicular size (HP:0008734) | 1.71646696 |
184 | Achilles tendon contracture (HP:0001771) | 1.70627407 |
185 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.69400876 |
186 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.69400876 |
187 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.69400876 |
188 | Abnormality of the dental pulp (HP:0006479) | 1.68976012 |
189 | Narrow forehead (HP:0000341) | 1.65403163 |
190 | Amyloidosis (HP:0011034) | 1.65307201 |
191 | Hydroureter (HP:0000072) | 1.63202826 |
192 | Bradycardia (HP:0001662) | 1.63076925 |
193 | Supraventricular tachycardia (HP:0004755) | 1.61797120 |
194 | Agitation (HP:0000713) | 1.61734161 |
195 | Abnormality of the renal medulla (HP:0100957) | 1.61578293 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PHKG1 | 6.28996770 |
2 | PHKG2 | 6.28996770 |
3 | MAPK15 | 5.15930228 |
4 | NME2 | 4.29013261 |
5 | EPHA2 | 4.28458827 |
6 | TESK2 | 4.11258782 |
7 | VRK2 | 3.73050474 |
8 | CDK8 | 3.69431807 |
9 | TESK1 | 3.40158415 |
10 | MST1R | 3.18272769 |
11 | NUAK1 | 3.16533395 |
12 | TRIB3 | 3.14088853 |
13 | LIMK1 | 2.97099194 |
14 | SIK2 | 2.89714901 |
15 | CAMK2D | 2.61500480 |
16 | BUB1 | 2.59078795 |
17 | CAMK2B | 2.57275667 |
18 | PAK3 | 2.50171958 |
19 | MOS | 2.45966645 |
20 | MST4 | 2.35868579 |
21 | STK10 | 2.33977386 |
22 | ARAF | 2.26915921 |
23 | CAMK1G | 2.23063168 |
24 | ILK | 2.21457165 |
25 | IRAK3 | 2.20306632 |
26 | CAMKK2 | 2.14033301 |
27 | CAMK1D | 2.12519214 |
28 | CAMK2G | 2.09586866 |
29 | STK24 | 1.97757605 |
30 | ERBB3 | 1.91207011 |
31 | CSNK1A1L | 1.81502331 |
32 | DAPK2 | 1.70057448 |
33 | TGFBR2 | 1.66934609 |
34 | SMG1 | 1.64204453 |
35 | TAOK2 | 1.62209296 |
36 | GRK7 | 1.59929685 |
37 | PAK4 | 1.57584758 |
38 | CSNK1G3 | 1.54395454 |
39 | RIPK1 | 1.51280832 |
40 | ICK | 1.41830337 |
41 | ERN1 | 1.35607219 |
42 | CSNK1G1 | 1.35563466 |
43 | CSNK1G2 | 1.33860470 |
44 | STK16 | 1.33155013 |
45 | MAP3K12 | 1.29771419 |
46 | SCYL2 | 1.26488381 |
47 | PRKCG | 1.24209895 |
48 | SIK1 | 1.22704034 |
49 | FRK | 1.20302840 |
50 | DYRK3 | 1.20019635 |
51 | MAP3K3 | 1.17850790 |
52 | PBK | 1.15603866 |
53 | ABL2 | 1.15251097 |
54 | HIPK2 | 1.14545689 |
55 | MET | 1.13165454 |
56 | PTK2 | 1.10802424 |
57 | CDK19 | 1.05364321 |
58 | GRK6 | 0.98936861 |
59 | CAMKK1 | 0.97516548 |
60 | PIM2 | 0.96760219 |
61 | KDR | 0.95036133 |
62 | MAPKAPK3 | 0.91592917 |
63 | DAPK1 | 0.85713100 |
64 | LRRK2 | 0.85219983 |
65 | EPHB2 | 0.84206848 |
66 | PRKCI | 0.81678087 |
67 | CAMK2A | 0.81161906 |
68 | ERBB4 | 0.80912987 |
69 | MAP3K8 | 0.77932433 |
70 | AURKA | 0.77847588 |
71 | GRK5 | 0.77371144 |
72 | EIF2AK2 | 0.75515769 |
73 | RPS6KA2 | 0.75498594 |
74 | MAP2K7 | 0.74361589 |
75 | TBK1 | 0.73934813 |
76 | EPHB1 | 0.72246970 |
77 | CCNB1 | 0.71912847 |
78 | MAPK7 | 0.71450929 |
79 | STK39 | 0.71445162 |
80 | STK11 | 0.70544393 |
81 | EIF2AK1 | 0.70244715 |
82 | EEF2K | 0.69264843 |
83 | CDK12 | 0.69259943 |
84 | MAP3K11 | 0.67991081 |
85 | ZAK | 0.67640710 |
86 | TAF1 | 0.66951197 |
87 | CDK3 | 0.66576893 |
88 | MAP3K2 | 0.62226024 |
89 | DYRK1B | 0.61375030 |
90 | SGK223 | 0.59685874 |
91 | SGK494 | 0.59685874 |
92 | PAK1 | 0.59394888 |
93 | BRSK1 | 0.59138389 |
94 | MAP3K10 | 0.58095200 |
95 | VRK1 | 0.58018028 |
96 | MELK | 0.57686506 |
97 | MAP2K3 | 0.56919895 |
98 | MINK1 | 0.55925678 |
99 | BCKDK | 0.54064452 |
100 | MAP3K4 | 0.52467196 |
101 | PRPF4B | 0.52157248 |
102 | MYLK | 0.50160837 |
103 | DAPK3 | 0.48192883 |
104 | PNCK | 0.47002666 |
105 | NME1 | 0.45661768 |
106 | CAMK4 | 0.45374189 |
107 | MARK2 | 0.44086983 |
108 | IRAK1 | 0.44042280 |
109 | NEK1 | 0.42711971 |
110 | PRKG2 | 0.42382187 |
111 | DYRK1A | 0.41692593 |
112 | STK4 | 0.40774341 |
113 | FER | 0.40542968 |
114 | PRKCZ | 0.40268469 |
115 | PRKAA2 | 0.39867867 |
116 | AKT2 | 0.39301005 |
117 | ROCK2 | 0.39175837 |
118 | CHEK2 | 0.38546344 |
119 | RAF1 | 0.38327315 |
120 | STK38 | 0.38318216 |
121 | PLK2 | 0.37447514 |
122 | CLK1 | 0.37244047 |
123 | BRAF | 0.36799431 |
124 | CDK5 | 0.36759741 |
125 | BMX | 0.35366827 |
126 | PLK1 | 0.34482740 |
127 | CAMK1 | 0.33407904 |
128 | CDK7 | 0.33257920 |
129 | CDK14 | 0.33092663 |
130 | CDK9 | 0.32155959 |
131 | PRKCQ | 0.30588576 |
132 | PRKD1 | 0.30277028 |
133 | RPS6KA5 | 0.30161262 |
134 | ADRBK1 | 0.30040750 |
135 | PRKD2 | 0.29757205 |
136 | CDK11A | 0.29078109 |
137 | PRKCE | 0.28579687 |
138 | AURKB | 0.28324221 |
139 | SGK2 | 0.27673385 |
140 | CDK15 | 0.27353437 |
141 | MUSK | 0.26490035 |
142 | MAPKAPK2 | 0.26074862 |
143 | CDK18 | 0.25630865 |
144 | LATS2 | 0.25173571 |
145 | LMTK2 | 0.24830296 |
146 | RPS6KA4 | 0.24819467 |
147 | MAP2K4 | 0.24761311 |
148 | CSF1R | 0.24626144 |
149 | PDPK1 | 0.23939519 |
150 | FYN | 0.23617829 |
151 | AKT3 | 0.23615560 |
152 | MAPK10 | 0.22695485 |
153 | NEK2 | 0.22615194 |
154 | PTK2B | 0.22576974 |
155 | CASK | 0.22532261 |
156 | MARK1 | 0.22305220 |
157 | FGFR2 | 0.22240582 |
158 | MARK3 | 0.21936173 |
159 | NLK | 0.20634266 |
160 | STK38L | 0.20368062 |
161 | CSK | 0.19565903 |
162 | TTK | 0.19528199 |
163 | MAP3K7 | 0.18560827 |
164 | CSNK1A1 | 0.18061863 |
165 | TTN | 0.17833262 |
166 | PRKG1 | 0.17800719 |
167 | PRKCA | 0.17108133 |
168 | PRKACA | 0.16919083 |
169 | NTRK2 | 0.16275325 |
170 | PRKACG | 0.15779491 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 4.37254774 |
2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.29453304 |
3 | Mismatch repair_Homo sapiens_hsa03430 | 2.89598475 |
4 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.89564272 |
5 | DNA replication_Homo sapiens_hsa03030 | 2.57055648 |
6 | Carbon metabolism_Homo sapiens_hsa01200 | 2.50668481 |
7 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.50230413 |
8 | Base excision repair_Homo sapiens_hsa03410 | 2.30394049 |
9 | Phototransduction_Homo sapiens_hsa04744 | 2.18570443 |
10 | Olfactory transduction_Homo sapiens_hsa04740 | 12.2222530 |
11 | Galactose metabolism_Homo sapiens_hsa00052 | 1.97793615 |
12 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.84361012 |
13 | Ribosome_Homo sapiens_hsa03010 | 1.82980926 |
14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.81898983 |
15 | Taste transduction_Homo sapiens_hsa04742 | 1.76582062 |
16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.71582723 |
17 | Morphine addiction_Homo sapiens_hsa05032 | 1.70135524 |
18 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.65846347 |
19 | Insulin secretion_Homo sapiens_hsa04911 | 1.60997143 |
20 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.58270158 |
21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53780037 |
22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.53455397 |
23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.52419890 |
24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.49295944 |
25 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.44253030 |
26 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.44201257 |
27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.43812912 |
28 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.41436468 |
29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40997101 |
30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.39184645 |
31 | Bile secretion_Homo sapiens_hsa04976 | 1.29708961 |
32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.28966170 |
33 | Salivary secretion_Homo sapiens_hsa04970 | 1.28719621 |
34 | RNA polymerase_Homo sapiens_hsa03020 | 1.28708178 |
35 | GABAergic synapse_Homo sapiens_hsa04727 | 1.27052430 |
36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.25373258 |
37 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.25009897 |
38 | Apoptosis_Homo sapiens_hsa04210 | 1.24445954 |
39 | Lysosome_Homo sapiens_hsa04142 | 1.18231042 |
40 | Homologous recombination_Homo sapiens_hsa03440 | 1.16566747 |
41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.14067723 |
42 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.13489153 |
43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.12657078 |
44 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.12514752 |
45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11477740 |
46 | Cell cycle_Homo sapiens_hsa04110 | 1.10437698 |
47 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.06414112 |
48 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04624476 |
49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.03424529 |
50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00138173 |
51 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.99086830 |
52 | Parkinsons disease_Homo sapiens_hsa05012 | 0.98513712 |
53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97746325 |
54 | Bladder cancer_Homo sapiens_hsa05219 | 0.97346827 |
55 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.96522420 |
56 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.96473768 |
57 | Renin secretion_Homo sapiens_hsa04924 | 0.95129726 |
58 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.95010797 |
59 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.93768312 |
60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91877573 |
61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.90823435 |
62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.90177951 |
63 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.88186339 |
64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87592608 |
65 | Alcoholism_Homo sapiens_hsa05034 | 0.87562009 |
66 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.87051632 |
67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85521670 |
68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84445405 |
69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84260867 |
70 | Shigellosis_Homo sapiens_hsa05131 | 0.82911790 |
71 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81899943 |
72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81819246 |
73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81033083 |
74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78641978 |
75 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78238061 |
76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76984199 |
77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74495790 |
78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74278729 |
79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72487400 |
80 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.70078928 |
81 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69423467 |
82 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.68951451 |
83 | Melanogenesis_Homo sapiens_hsa04916 | 0.68867263 |
84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68561860 |
85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68095501 |
86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67601072 |
87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.67109667 |
88 | Gap junction_Homo sapiens_hsa04540 | 0.66771311 |
89 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66589960 |
90 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.64437339 |
91 | Long-term potentiation_Homo sapiens_hsa04720 | 0.64166168 |
92 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.61962543 |
93 | Basal transcription factors_Homo sapiens_hsa03022 | 0.59358691 |
94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58482501 |
95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58109023 |
96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58089069 |
97 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.57876742 |
98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57863663 |
99 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.57224230 |
100 | ABC transporters_Homo sapiens_hsa02010 | 0.56516056 |
101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56182075 |
102 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.55876713 |
103 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.55688147 |
104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54613508 |
105 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.54390465 |
106 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52506785 |
107 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.52476305 |
108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51688001 |
109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51371769 |
110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50285588 |
111 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.49432812 |
112 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49036437 |
113 | Endocytosis_Homo sapiens_hsa04144 | 0.48106451 |
114 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48101007 |
115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47012867 |
116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46647245 |
117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46147705 |
118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.46079771 |
119 | RNA degradation_Homo sapiens_hsa03018 | 0.44247292 |
120 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43786701 |
121 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43382308 |
122 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43258778 |
123 | Legionellosis_Homo sapiens_hsa05134 | 0.42311946 |
124 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.41652496 |
125 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.41398816 |
126 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40898536 |
127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40455648 |
128 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40026736 |
129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38958240 |
130 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38517704 |
131 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37728406 |
132 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37333436 |
133 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36779108 |
134 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36568000 |
135 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.36097920 |
136 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35411456 |
137 | Salmonella infection_Homo sapiens_hsa05132 | 0.34910290 |
138 | Purine metabolism_Homo sapiens_hsa00230 | 0.34864896 |
139 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.33484555 |
140 | Glioma_Homo sapiens_hsa05214 | 0.32457257 |
141 | Nicotine addiction_Homo sapiens_hsa05033 | 0.31047848 |
142 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.29851546 |
143 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29804610 |
144 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.29682274 |
145 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29630572 |
146 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.29530262 |
147 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.29399828 |
148 | Axon guidance_Homo sapiens_hsa04360 | 0.29281287 |
149 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28339162 |
150 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27248645 |
151 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27040105 |
152 | Prion diseases_Homo sapiens_hsa05020 | 0.26560379 |
153 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.26538667 |
154 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26036326 |
155 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25795405 |
156 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.25285934 |
157 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.25152907 |
158 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.23643805 |
159 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.23562256 |
160 | Thyroid cancer_Homo sapiens_hsa05216 | 0.23111759 |
161 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.22907033 |
162 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.22754296 |
163 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.22741044 |
164 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22717392 |
165 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.21170013 |
166 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.20752325 |
167 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.20596700 |
168 | Amoebiasis_Homo sapiens_hsa05146 | 0.19629802 |
169 | Peroxisome_Homo sapiens_hsa04146 | 0.19460387 |
170 | Phagosome_Homo sapiens_hsa04145 | 0.19280779 |
171 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.18824948 |
172 | Pertussis_Homo sapiens_hsa05133 | 0.17366873 |
173 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.16682806 |
174 | RNA transport_Homo sapiens_hsa03013 | 0.16311328 |
175 | Mineral absorption_Homo sapiens_hsa04978 | 0.16143479 |
176 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.14228260 |
177 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.13781914 |
178 | HTLV-I infection_Homo sapiens_hsa05166 | 0.12576436 |